annual cash & cash equivalents:
$582.24M+$148.75M(+34.31%)Summary
- As of today (August 20, 2025), ASND annual cash & cash equivalents is $582.24 million, with the most recent change of +$148.75 million (+34.31%) on December 31, 2024.
- During the last 3 years, ASND annual cash & cash equivalents has risen by +$76.97 million (+15.23%).
- ASND annual cash & cash equivalents is now -19.01% below its all-time high of $718.93 million, reached on December 31, 2020.
Performance
ASND Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$579.94M+$20.48M(+3.66%)Summary
- As of today (August 20, 2025), ASND quarterly cash & cash equivalents is $579.94 million, with the most recent change of +$20.48 million (+3.66%) on June 1, 2025.
- Over the past year, ASND quarterly cash & cash equivalents has increased by +$302.68 million (+109.17%).
- ASND quarterly cash & cash equivalents is now -46.81% below its all-time high of $1.09 billion, reached on September 30, 2020.
Performance
ASND quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
ASND Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +34.3% | +109.2% |
| 3 y3 years | +15.2% | -41.9% |
| 5 y5 years | -13.1% | +9.5% |
ASND Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +34.3% | -41.9% | +109.2% |
| 5 y | 5-year | -19.0% | +34.3% | -46.8% | +109.2% |
| alltime | all time | -19.0% | +2929.0% | -46.8% | +5704.6% |
ASND Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $579.94M(+3.7%) |
| Mar 2025 | - | $559.46M(-3.4%) |
| Dec 2024 | $582.24M(+34.3%) | $579.41M(-17.0%) |
| Sep 2024 | - | $698.11M(+151.8%) |
| Jun 2024 | - | $277.26M(-19.8%) |
| Mar 2024 | - | $345.86M(-21.6%) |
| Dec 2023 | $433.50M(-9.1%) | $441.24M(-8.5%) |
| Sep 2023 | - | $482.19M(+2.5%) |
| Jun 2023 | - | $470.33M(-26.1%) |
| Mar 2023 | - | $636.38M(-18.9%) |
| Dec 2022 | $476.97M(-5.6%) | $784.91M(-12.9%) |
| Sep 2022 | - | $901.09M(-9.8%) |
| Jun 2022 | - | $998.57M(-8.3%) |
| Mar 2022 | - | $1.09B(+40.4%) |
| Dec 2021 | $505.27M(-29.7%) | $775.64M(-22.0%) |
| Sep 2021 | - | $994.71M(+52.3%) |
| Jun 2021 | - | $653.00M(-16.4%) |
| Mar 2021 | - | $781.23M(-11.2%) |
| Dec 2020 | $718.93M(+7.3%) | $879.48M(-19.3%) |
| Sep 2020 | - | $1.09B(+105.9%) |
| Jun 2020 | - | $529.64M(-9.7%) |
| Mar 2020 | - | $586.35M(-12.7%) |
| Dec 2019 | $669.98M | $671.37M(-6.5%) |
| Sep 2019 | - | $718.07M(-8.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | $786.18M(+0.5%) |
| Mar 2019 | - | $782.25M(+146.3%) |
| Dec 2018 | $317.85M(+35.6%) | $317.64M(-11.9%) |
| Sep 2018 | - | $360.45M(-12.4%) |
| Jun 2018 | - | $411.68M(-3.9%) |
| Mar 2018 | - | $428.49M(+82.7%) |
| Dec 2017 | $234.36M(+22.9%) | $234.58M(-3.8%) |
| Sep 2017 | - | $243.88M(+67.9%) |
| Jun 2017 | - | $145.21M(-13.9%) |
| Mar 2017 | - | $168.61M(-11.4%) |
| Dec 2016 | $190.64M(+45.7%) | $190.20M(+127.1%) |
| Sep 2016 | - | $83.75M(-16.9%) |
| Jun 2016 | - | $100.82M(-13.1%) |
| Mar 2016 | - | $116.08M(-10.7%) |
| Dec 2015 | $130.81M(+114.4%) | $129.97M(-9.2%) |
| Sep 2015 | - | $143.16M(-6.8%) |
| Jun 2015 | - | $153.60M(+153.0%) |
| Dec 2014 | $61.00M(+127.4%) | $60.70M(+507.6%) |
| Sep 2014 | - | $9.99M(-37.9%) |
| Jun 2014 | - | $16.10M(-39.9%) |
| Dec 2013 | $26.83M(+39.6%) | $26.77M(-14.3%) |
| Sep 2013 | - | $31.25M(+90.2%) |
| Jun 2013 | - | $16.43M |
| Dec 2012 | $19.22M(-5.4%) | - |
| Dec 2011 | $20.31M | - |
FAQ
- What is Ascendis Pharma A/S annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Ascendis Pharma A/S?
- What is Ascendis Pharma A/S annual cash & cash equivalents year-on-year change?
- What is Ascendis Pharma A/S quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Ascendis Pharma A/S?
- What is Ascendis Pharma A/S quarterly cash & cash equivalents year-on-year change?
What is Ascendis Pharma A/S annual cash & cash equivalents?
The current annual cash & cash equivalents of ASND is $582.24M
What is the all time high annual cash & cash equivalents for Ascendis Pharma A/S?
Ascendis Pharma A/S all-time high annual cash & cash equivalents is $718.93M
What is Ascendis Pharma A/S annual cash & cash equivalents year-on-year change?
Over the past year, ASND annual cash & cash equivalents has changed by +$148.75M (+34.31%)
What is Ascendis Pharma A/S quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of ASND is $579.94M
What is the all time high quarterly cash & cash equivalents for Ascendis Pharma A/S?
Ascendis Pharma A/S all-time high quarterly cash & cash equivalents is $1.09B
What is Ascendis Pharma A/S quarterly cash & cash equivalents year-on-year change?
Over the past year, ASND quarterly cash & cash equivalents has changed by +$302.68M (+109.17%)